I-STAT B-HCG CARTRIDGE
Report
- Report Number
- 2245578-2019-00013
- Event Type
- Malfunction
- Date Received
- January 22, 2019
- Date of Event
- January 12, 2019
- Report Date
- February 13, 2019
- Manufacturer
- ABBOTT POINT OF CARE
- Product Code
- DHA
- UDI-DI
- 10054749001009
- PMA / PMN Number
- K133002
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- KS, US
- Reporter Occupation
- OTHER HEALTH CARE PROFESSIONAL
Narratives
APOC INCIDENT #: (B)(4). THE INVESTIGATION WAS COMPLETED ON 02/05/2019. A REVIEW OF THE DEVICE HISTORY RECORD (DHR) CONFIRMED THAT THE CARTRIDGE LOT MET FINISHED GOODS (FG) RELEASE CRITERIA. RETAINED AND RETURNED CARTRIDGE TESTING MET THE ACCEPTANCE CRITERIA OUTLINED IN APPENDIX 1 OF Q04.01.003 REV. AC (PRODUCT COMPLAINT LEVEL 2 AND LEVEL 3 INVESTIGATION PROCEDURE).NO DEFICIENCY HAS BEEN IDENTIFIED FOR SS-HCG CARTRIDGE LOT F18331.
NA.
(B)(4). APOC LABELING WILL BE EVALUATED DURING THE INVESTIGATION AS PERTAINING TO THE EVENT.
ON (B)(6) 2019, ABBOTT POINT OF CARE (APOC) WAS CONTACTED BY A CUSTOMER REGARDING I-STAT B-HCG CARTRIDGES THAT YIELDED SUSPECTED FALSE POSITIVE RESULTS ON A (B)(6) FEMALE PATIENT WITH A VAGINAL BLEED. THERE WAS NO ADDITIONAL PATIENT INFORMATION. RETURN PRODUCT IS AVAILABLE FOR INVESTIGATION. (B)(6). THERE ARE NO INJURIES ASSOCIATED WITH THIS EVENT. AT THIS TIME THERE IS NO REASON TO SUSPECT A MALFUNCTION EXISTS. IT IS SUSPECTED THAT THE POSITIVE RESULTS ON I-STAT ARE POTENTIALLY RELATED TO A HETEROPHILIC ANTIBODY BUT UNCONFIRMED AT THIS TIME. THE CUSTOMER STATED THAT THE PATIENT WAS NOT PREGNANT AND WAS REFERRED TO GYNECOLOGIST. THE REPORTING DECISION WAS BASED ON INFORMATION AVAILABLE THAT SUGGESTS THE PRODUCT WAS NOT PERFORMING WITHIN THE VARIABILITY OF THE ASSAY. THE INVESTIGATION IS UNDERWAY.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 61279 | I-STAT B-HCG CARTRIDGE | B-HCG CARTRIDGE | DHA | ABBOTT POINT OF CARE | NA | F18331 | 10054749001009 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 30 YR |